Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine
  4. Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
 
  • Details
Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
File(s)
s13550-017-0325-9.pdf (230.46 KB)
Published version
Author(s)
Saleem, A
Searle, GE
Kenny, LM
Huiban, M
Kozlowski, K
more
Type
Journal Article
Date Issued
2017-09-18
Date Acceptance
2017-09-07
URI
http://hdl.handle.net/10044/1/50864
DOI
https://dx.doi.org/10.1186/s13550-017-0325-9
ISSN
2191-219X
Start Page
76
Journal / Book Title
EJNMMI Res
Volume
7
Issue
1
Copyright Statement
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Sponsor
Imperial College Healthcare NHS Trust- BRC Funding
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/28921454
10.1186/s13550-017-0325-9
Grant Number
RDC04 79560
Publication Status
Published online
Coverage Spatial
Germany
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback